Inhalation of the novel tryptophan hydroxylase 1 inhibitor TPT-004 alleviates pulmonary arterial hypertension
Inhaled pharmacotherapies are promising treatment options for patients with pulmonary arterial hypertension (PAH), as they minimize extrapulmonary adverse effects. Recently, we developed a highly specific tryptophan hydroxylase 1 inhibitor (TPHi): TPT-004. We hypothesized that repetitive nose-only i...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
August 2025
|
| In: |
American journal of respiratory cell and molecular biology
Year: 2025, Jahrgang: 73, Heft: 2, Pages: 288-298 |
| ISSN: | 1535-4989 |
| DOI: | 10.1165/rcmb.2024-0365OC |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1165/rcmb.2024-0365OC Verlag, lizenzpflichtig, Volltext: https://www-atsjournals-org.ezproxy.medma.uni-heidelberg.de/doi/10.1165/rcmb.2024-0365OC 
|
| Verfasserangaben: | Ekaterina Legchenko, Philippe Chouvarine, Klea Hysko, Fatimunnisa Qadri, Radoslaw Wesolowski, Edgar Specker, Silke Glage, Martin Meier, Katharina Schwarz, Joerg Heineke, Gerhard Pohlmann, Mehmet Ramazanoglu, Michael Bader, Georg Hansmann |
MARC
| LEADER | 00000naa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1940058392 | ||
| 003 | DE-627 | ||
| 005 | 20251103115242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251103s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1165/rcmb.2024-0365OC |2 doi | |
| 035 | |a (DE-627)1940058392 | ||
| 035 | |a (DE-599)KXP1940058392 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Legchenko, Ekaterina |d 1989- |e VerfasserIn |0 (DE-588)1181484251 |0 (DE-627)1662668287 |4 aut | |
| 245 | 1 | 0 | |a Inhalation of the novel tryptophan hydroxylase 1 inhibitor TPT-004 alleviates pulmonary arterial hypertension |c Ekaterina Legchenko, Philippe Chouvarine, Klea Hysko, Fatimunnisa Qadri, Radoslaw Wesolowski, Edgar Specker, Silke Glage, Martin Meier, Katharina Schwarz, Joerg Heineke, Gerhard Pohlmann, Mehmet Ramazanoglu, Michael Bader, Georg Hansmann |
| 264 | 1 | |c August 2025 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Ursprünglich veröffentlicht: 3. February 2025 | ||
| 500 | |a Gesehen am 03.11.2025 | ||
| 520 | |a Inhaled pharmacotherapies are promising treatment options for patients with pulmonary arterial hypertension (PAH), as they minimize extrapulmonary adverse effects. Recently, we developed a highly specific tryptophan hydroxylase 1 inhibitor (TPHi): TPT-004. We hypothesized that repetitive nose-only inhalation of TPT-004 alleviates PAH and pulmonary vascular remodeling in the Sugen 5416/hypoxia (SuHx) rat model. Male Sprague Dawley rats were divided into three groups: ConNx (control animals kept in room air during the study); SuHx+vehicle (rats injected with the VEGFR2 inhibitor SU5416 and then exposed to chronic hypoxia for 3 weeks, followed by 10 days recovery and subsequent 4 weeks of daily vehicle inhalations; and SuHx+TPHi (SuHx-exposed rats after recovery treated with daily inhalations of the TPH1 inhibitor, TPT-004, for 4 weeks). Closed-chest right-left heart catheterization and cardiac magnetic resonance imaging were performed in spontaneously breathing rats. Histological and mRNA-sequencing analyses were performed on lungs. SuHx-exposed rats had severe PAH, right ventricle (RV) hypertrophy, and RV dilation. In comparison with SuHx-exposed rats, TPHi-treated SuHx rats had significantly lower RV systolic pressure (67.25 vs. 51.47 mm Hg; P < 0.0001), normalized RV end-systolic volume (182.6 vs. 105.1 μl; P < 0.0001), and improved RV ejection fraction by cardiac magnetic resonance imaging (47.9 vs. 66.8%; P < 0.0001). Inhaled TPT-004 did not affect left ventricular (LV) end-diastolic or systemic blood pressure. TPT-004 therapy reversed pulmonary vascular remodeling and alveolar macrophage infiltration. RNA sequencing unraveled TPHi-induced changes in pulmonary gene expression: increased cell adhesion as well as reduced cell motility and migration; suppressed extracellular matrix remodeling; modulated immune response; and suppressed pulmonary vascular remodeling by means of modulating proliferation, apoptosis, and homeostasis. Taken together, TPT-004 is an effective therapeutic PAH agent that does not cause any hemodynamic adverse effects in rodents, and thus, should be tested further towards a clinical phase 1b/phase 2 study in patients with PAH. | ||
| 650 | 4 | |a inhaled therapy | |
| 650 | 4 | |a pulmonary hypertension | |
| 650 | 4 | |a pulmonary vascular disease | |
| 650 | 4 | |a serotonin | |
| 650 | 4 | |a tryptophan hydroxylase 1 inhibitor | |
| 700 | 1 | |a Chouvarine, Philippe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hysko, Klea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Qadri, Fatimunnisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wesolowski, Radoslaw |e VerfasserIn |4 aut | |
| 700 | 1 | |a Specker, Edgar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Glage, Silke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Meier, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schwarz, Katharina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heineke, Jörg |d 1974- |e VerfasserIn |0 (DE-588)122672321 |0 (DE-627)082082715 |0 (DE-576)293374805 |4 aut | |
| 700 | 1 | |a Pohlmann, Gerhard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ramazanoglu, Mehmet |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bader, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hansmann, Georg |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of respiratory cell and molecular biology |d New York, NY : Assoc., 1994 |g 73(2025), 2 vom: Aug., Seite 288-298 |h Online-Ressource |w (DE-627)269017321 |w (DE-600)1473629-9 |w (DE-576)077662245 |x 1535-4989 |7 nnas |a Inhalation of the novel tryptophan hydroxylase 1 inhibitor TPT-004 alleviates pulmonary arterial hypertension |
| 773 | 1 | 8 | |g volume:73 |g year:2025 |g number:2 |g month:08 |g pages:288-298 |g extent:11 |a Inhalation of the novel tryptophan hydroxylase 1 inhibitor TPT-004 alleviates pulmonary arterial hypertension |
| 856 | 4 | 0 | |u https://doi.org/10.1165/rcmb.2024-0365OC |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www-atsjournals-org.ezproxy.medma.uni-heidelberg.de/doi/10.1165/rcmb.2024-0365OC |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251103 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 122672321 |a Heineke, Jörg |m 122672321:Heineke, Jörg |d 60000 |d 65000 |e 60000PH122672321 |e 65000PH122672321 |k 0/60000/ |k 1/60000/65000/ |p 10 | ||
| 998 | |g 1181484251 |a Legchenko, Ekaterina |m 1181484251:Legchenko, Ekaterina |d 60000 |d 65000 |e 60000PL1181484251 |e 65000PL1181484251 |k 0/60000/ |k 1/60000/65000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1940058392 |e 4795728925 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"Inhalation of the novel tryptophan hydroxylase 1 inhibitor TPT-004 alleviates pulmonary arterial hypertension","title_sort":"Inhalation of the novel tryptophan hydroxylase 1 inhibitor TPT-004 alleviates pulmonary arterial hypertension"}],"person":[{"family":"Legchenko","given":"Ekaterina","role":"aut","display":"Legchenko, Ekaterina"},{"family":"Chouvarine","given":"Philippe","role":"aut","display":"Chouvarine, Philippe"},{"given":"Klea","role":"aut","display":"Hysko, Klea","family":"Hysko"},{"family":"Qadri","role":"aut","given":"Fatimunnisa","display":"Qadri, Fatimunnisa"},{"display":"Wesolowski, Radoslaw","given":"Radoslaw","role":"aut","family":"Wesolowski"},{"family":"Specker","role":"aut","given":"Edgar","display":"Specker, Edgar"},{"role":"aut","given":"Silke","display":"Glage, Silke","family":"Glage"},{"family":"Meier","given":"Martin","role":"aut","display":"Meier, Martin"},{"role":"aut","given":"Katharina","display":"Schwarz, Katharina","family":"Schwarz"},{"family":"Heineke","display":"Heineke, Jörg","given":"Jörg","role":"aut"},{"family":"Pohlmann","display":"Pohlmann, Gerhard","given":"Gerhard","role":"aut"},{"display":"Ramazanoglu, Mehmet","role":"aut","given":"Mehmet","family":"Ramazanoglu"},{"family":"Bader","display":"Bader, Michael","given":"Michael","role":"aut"},{"family":"Hansmann","display":"Hansmann, Georg","role":"aut","given":"Georg"}],"name":{"displayForm":["Ekaterina Legchenko, Philippe Chouvarine, Klea Hysko, Fatimunnisa Qadri, Radoslaw Wesolowski, Edgar Specker, Silke Glage, Martin Meier, Katharina Schwarz, Joerg Heineke, Gerhard Pohlmann, Mehmet Ramazanoglu, Michael Bader, Georg Hansmann"]},"note":["Ursprünglich veröffentlicht: 3. February 2025","Gesehen am 03.11.2025"],"relHost":[{"pubHistory":["Nachgewiesen 10.1994 -"],"title":[{"subtitle":"an official journal of the American Thoracic Society Medical Section of the American Lung Association","title":"American journal of respiratory cell and molecular biology","title_sort":"American journal of respiratory cell and molecular biology"}],"part":{"pages":"288-298","extent":"11","issue":"2","volume":"73","text":"73(2025), 2 vom: Aug., Seite 288-298","year":"2025"},"language":["eng"],"disp":"Inhalation of the novel tryptophan hydroxylase 1 inhibitor TPT-004 alleviates pulmonary arterial hypertensionAmerican journal of respiratory cell and molecular biology","id":{"eki":["269017321"],"issn":["1535-4989"],"zdb":["1473629-9"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 31.07.13"],"recId":"269017321","origin":[{"publisher":"Assoc.","dateIssuedDisp":"1994-","dateIssuedKey":"1994","publisherPlace":"New York, NY"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"AJRCMB"},{"title":"Respiratory cell and molecular biology"}]}],"id":{"eki":["1940058392"],"doi":["10.1165/rcmb.2024-0365OC"]},"physDesc":[{"extent":"11 S."}],"recId":"1940058392","origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"August 2025"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a LEGCHENKOEINHALATION2025 | ||